Welcome to the new morningstar.co.uk! Learn more about the changes and how our new features help your investing success.

OptiBiotix Health Subsidiary Inks License Agreement With Nutrilinea

LONDON (Alliance News) - OptiBiotix Health PLC on Monday said that subsidiary ProBiotix Health ...

Alliance News 20 May, 2019 | 1:20PM
Email Form

LONDON (Alliance News) - OptiBiotix Health PLC on Monday said that subsidiary ProBiotix Health Ltd has signed a licence agreement with Nutrilinea Srl.

The deal covers the use of Optibiotix's LPLDL in a food supplement for the reduction of high blood pressure.

Nutrilinea, an Italian company manufacturing food supplements, will cover the cost of all product development, manufacturing and human studies in return for 12 months exclusivity for the European market, the company explained. ProBiotix has exclusivity for the UK and all other markets outside Europe.

OptiBiotix Health shares were trading 2.2% higher at 85.35 pence each on Monday afternoon.

By Elena Cherubini; elenacherubini@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

Email Form

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
OptiBiotix Health PLC 53.00 GBX 4.95 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

Audience Confirmation


By clicking 'accept' I acknowledge that this website uses cookies and other technologies to tailor my experience and understand how I and other visitors use our site. See 'Cookie Consent' for more detail.

  • Other Morningstar Websites